Docetaxel polymeric nanoparticle (Samyang Biopharmaceuticals)
多西他赛聚合物纳米颗粒
Report date: 2025/04/29 21:23:13
Base Information
Drug NameDocetaxel polymeric nanoparticle (Samyang Biopharmaceuticals)
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSamyang Biopharmaceuticals Corp
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSamyang Biopharmaceuticals Corp
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A